{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:02:09Z","timestamp":1790744529684,"version":"4.1.0"},"reference-count":26,"publisher":"American Diabetes Association","issue":"10","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,10,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Gastroparesis is a disorder of delayed gastric emptying that is often chronic in nature. Up to 50% of type 1 diabetic subjects have symptoms of gastroparesis, which include nausea, vomiting, and early satiety. Elevated pyloric pressures may be responsible for delayed gastric emptying in diabetic subjects. Botulinum toxin inhibits the release of acetylcholine and produces transient paralysis when injected into smooth muscle. The aim of this study was to determine whether injection of the pylorus with botulinum toxin in patients with diabetic gastroparesis improves symptoms of gastroparesis, alters gastric emptying scan time, and\/or changes weight and insulin use.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014This was an open-label trial with age- and sex-matched control subjects from a tertiary care referral center for patients with gastroparesis. Eight type 1 diabetic subjects (six women and two men; mean age 41 years; mean years with diabetes 25.3) who had failed standard therapy were enrolled. Intervention consisted of injection of the pylorus with 200 units of botulinum toxin during upper endoscopy. Symptoms, antropyloric manometry, gastric emptying scan times, weight, and insulin use were all recorded before intervention and during a 12-week follow-up period.<\/jats:p>\n               <jats:p>RESULTS\u2014Seven of the eight patients completed the full 12-week follow-up period. No complications were noted. Mean symptom scores declined from 27 to 12.1 (P &amp;lt; 0.01), whereas the SF-36 physical functioning domain also improved (P &amp;lt; 0.05). Four patients noted an increase in insulin use of &amp;gt;5 units\/day. Six of the seven patients gained weight (P = 0.05). Gastric emptying scan time improved in four patients.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Botulinum toxin injection of the pylorus is safe and improves symptoms in patients with diabetic gastroparesis. These results warrant further investigation with a large, double-blind, placebo-controlled trial.<\/jats:p>","DOI":"10.2337\/diacare.27.10.2341","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"2341-2347","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":125,"title":["The Treatment of Diabetic Gastroparesis With Botulinum Toxin Injection of the Pylorus"],"prefix":"10.2337","volume":"27","author":[{"given":"Brian E.","family":"Lacy","sequence":"first","affiliation":[{"name":"Marvin M. Schuster Center for Digestive and Motility Disorders, Johns Hopkins University, School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Crowell","sequence":"additional","affiliation":[{"name":"Novartis, East Hanover, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Schettler-Duncan","sequence":"additional","affiliation":[{"name":"Novartis, East Hanover, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Mathis","sequence":"additional","affiliation":[{"name":"Marvin M. Schuster Center for Digestive and Motility Disorders, Johns Hopkins University, School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj J.","family":"Pasricha","sequence":"additional","affiliation":[{"name":"University of Texas at Galveston, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031216015459100_R1","unstructured":"Koch K: Gastroparesis: diagnosis and management. Practical Gastroenterol\u200832: 30\u201343, 1987"},{"key":"2022031216015459100_R2","doi-asserted-by":"crossref","unstructured":"Horowitz M, Harding PE, Maddox A, Maddern GJ, Collins PJ, Chatterton BE, Wishart J, Shearman DJC: Gastric and oesophageal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol\u20081:97\u2013113, 1986","DOI":"10.1111\/j.1440-1746.1986.tb00104.x"},{"key":"2022031216015459100_R3","doi-asserted-by":"crossref","unstructured":"Rayner CK, Su YC, Doran SM, Jones KL, Malbert CH, Horowitz M: The stimulation of antral motility by erythromycin is attenuated by hyperglycemia. Am J Gastroenterol\u200895:2233\u20132241, 2000","DOI":"10.1111\/j.1572-0241.2000.02250.x"},{"key":"2022031216015459100_R4","doi-asserted-by":"crossref","unstructured":"Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G: Erythromycin is a motilin receptor agonist. Am J Physiol\u2008257:G470\u2013G474, 1989","DOI":"10.1152\/ajpgi.1989.257.3.G470"},{"key":"2022031216015459100_R5","doi-asserted-by":"crossref","unstructured":"Anese V, Janssens J, Vantrappen G, Tack J, Peeters TL, Willemse P, Van Cutsem E: Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination. Gastroenterology\u2008102:823\u2013828, 1992","DOI":"10.1016\/0016-5085(92)90164-T"},{"key":"2022031216015459100_R6","doi-asserted-by":"crossref","unstructured":"Albibi R, McCallum RW: Metoclopramide: pharmacology and clinical application. Ann Int Med\u200898:86\u201395, 1983","DOI":"10.7326\/0003-4819-98-1-86"},{"key":"2022031216015459100_R7","unstructured":"Soykan I, Sarosiek I, McCallum RW: The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol\u200892:976\u2013980, 1997"},{"key":"2022031216015459100_R8","doi-asserted-by":"crossref","unstructured":"Kendall BJ, Kendall ET, Soykan I, McCallum RW: Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study. J Int Med Res\u200825:182\u2013189, 1997","DOI":"10.1177\/030006059702500402"},{"key":"2022031216015459100_R9","doi-asserted-by":"crossref","unstructured":"Mearin F, Camilleri M, Malagelada JR: Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology\u200890:1919\u20131925, 1986","DOI":"10.1016\/0016-5085(86)90262-3"},{"key":"2022031216015459100_R10","doi-asserted-by":"crossref","unstructured":"Lacy BE, Zayat EN, Crowell MD, Schuster MM: Botulinum toxin for the treatment of gastroparesis (Abstract). Gastroenterology\u2008118:A624, 2000","DOI":"10.1016\/S0016-5085(00)84635-1"},{"key":"2022031216015459100_R11","doi-asserted-by":"crossref","unstructured":"Lacy BE, Zayat EN, Crowell MD, Schuster MM: Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol\u200897:1548\u20131552, 2002","DOI":"10.1111\/j.1572-0241.2002.05741.x"},{"key":"2022031216015459100_R12","doi-asserted-by":"crossref","unstructured":"Lacy BE, Schettler-Duncan VA, Crowell MD: The treatment of diabetic gastroparesis with botulinum toxin (Abstract). Am J Gastroenterol\u200895:2455, 2000","DOI":"10.1111\/j.1572-0241.2000.02514.x"},{"key":"2022031216015459100_R13","doi-asserted-by":"crossref","unstructured":"Gupta P, Rao SSC: Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. Gastrointest Endosc\u200856:104\u2013107, 2002","DOI":"10.1067\/mge.2002.129213"},{"key":"2022031216015459100_R14","doi-asserted-by":"crossref","unstructured":"Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS: Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc\u200855:920\u2013923, 2002","DOI":"10.1067\/mge.2002.124739"},{"key":"2022031216015459100_R15","doi-asserted-by":"crossref","unstructured":"Camilleri M, Hasler WL, Parkman HP, Quigley EMM, Soffer E: Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology\u2008115:747\u2013762, 1998","DOI":"10.1016\/S0016-5085(98)70155-6"},{"key":"2022031216015459100_R16","doi-asserted-by":"crossref","unstructured":"Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kaloo AN: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med\u2008332:774\u2013778, 1995","DOI":"10.1056\/NEJM199503233321203"},{"key":"2022031216015459100_R17","unstructured":"Fishman VM, Parkman HP, Schiano TD, Hills C, Dabezies MA, Cohen S, Fisher RS, Miller LS: Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol\u200891:1724\u20131730, 1996"},{"key":"2022031216015459100_R18","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Conference Statement: Clinical use of botulinum toxin. Arch Neurol\u200848:1294\u20131298, 1991","DOI":"10.1001\/archneur.1991.00530240100030"},{"key":"2022031216015459100_R19","doi-asserted-by":"crossref","unstructured":"Watkins CC, Sawa A, Jaffrey S: Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest\u2008106:373\u2013384, 2000","DOI":"10.1172\/JCI8273"},{"key":"2022031216015459100_R20","doi-asserted-by":"crossref","unstructured":"Martinek J, Siroky M, Plottova Z, Bures J, Hep A, Spicak J: Treatments of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus\u200816:204\u2013209, 2003","DOI":"10.1046\/j.1442-2050.2003.00329.x"},{"key":"2022031216015459100_R21","doi-asserted-by":"crossref","unstructured":"D\u2019Onofrio V, Miletto P, Leandro G, Iaquinto G: Long-term follow-up of achlasia patients treated with botulinum toxin. Dig Liver Dis\u200834:105\u2013110, 2002","DOI":"10.1016\/S1590-8658(02)80238-9"},{"key":"2022031216015459100_R22","doi-asserted-by":"crossref","unstructured":"Neubrand M, Scheurlen C, Schepke M, Sauerbruch T: Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy\u200834:519\u2013523, 2002","DOI":"10.1055\/s-2002-33225"},{"key":"2022031216015459100_R23","doi-asserted-by":"crossref","unstructured":"Bansal R, Nostrant TT, Scheiman JM, Koshy S, Barnett JL, Elta GH, Chey WD: Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol\u200836:209\u2013214, 2003","DOI":"10.1097\/00004836-200303000-00005"},{"key":"2022031216015459100_R24","doi-asserted-by":"crossref","unstructured":"Richter JE: Comparison and cost analysis of different treatment strategies in achalasia. Gastrointest Endosc Clin N Am\u200811:359\u2013370, 2001","DOI":"10.1016\/S1052-5157(18)30076-X"},{"key":"2022031216015459100_R25","doi-asserted-by":"crossref","unstructured":"Israel DM, Mahdi G, Hassall E: Pyloric balloon dilation for delayed gastric emptying in children. Can J Gastroenterol\u200815:723\u2013727, 2001","DOI":"10.1155\/2001\/615979"},{"key":"2022031216015459100_R26","doi-asserted-by":"crossref","unstructured":"Sun WM, Doran SM, Jones KL, Davidson G, Dent J, Horowitz M: Long-term effects of pyloromyotomy on pyloric motility and gastric emptying in humans. Am J Gastroenterol\u200895:92\u2013100, 2000","DOI":"10.1111\/j.1572-0241.2000.01705.x"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/27\/10\/2341\/561836\/zdc01004002341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/27\/10\/2341\/561836\/zdc01004002341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T16:18:13Z","timestamp":1647101893000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/27\/10\/2341\/23226\/The-Treatment-of-Diabetic-Gastroparesis-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.27.10.2341","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,1]]}}}